ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0724
0,00%
Bitcoin
63.999,08
0,17%
Brent Oil
83,125
0,43%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Johnson and Johnson (JNJ)

  7. Johnson and Johnson (JNJ) Notícias

JNJ

Johnson and Johnson (JNJ)

Johnson and Johnson
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:JNJ
DataHoraFonteTítuloCódigoCompanhia
01/05/202407:30Business WireJohnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” ReorganizationNYSE:JNJJohnson and Johnson
22/04/202417:30Business WireJohnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)NYSE:JNJJohnson and Johnson
19/04/202408:31IH Market NewsParamount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and MoreNYSE:JNJJohnson and Johnson
17/04/202407:59IH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:JNJJohnson and Johnson
16/04/202417:33IH Market NewsU.S. Stocks Finish Lackluster Session Narrowly MixedNYSE:JNJJohnson and Johnson
16/04/202411:46Business WireCORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
16/04/202410:52IH Market NewsJ&J’s Q1 2024 sales rise 2.3% to $21.4 billionNYSE:JNJJohnson and Johnson
16/04/202410:09IH Market NewsDow Looks To Snap Six-Day Losing Streak As UnitedHealth SurgesNYSE:JNJJohnson and Johnson
16/04/202408:19IH Market NewsU.S. Index Futures Signal Mixed Trading, Oil Prices DipNYSE:JNJJohnson and Johnson
16/04/202408:18IH Market NewsEricsson Soars with 66% Net Profit Growth; Live Nation Under Antitrust Scrutiny in US, and More NewsNYSE:JNJJohnson and Johnson
16/04/202407:25Business WireJohnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%NYSE:JNJJohnson and Johnson
16/04/202407:20Business WireJohnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
15/04/202417:38IH Market NewsU.S. Stocks Extend Sell-Off As Treasury Yields Surge After Retail Sales DataNYSE:JNJJohnson and Johnson
08/04/202419:06Business WireJohnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare ConferenceNYSE:JNJJohnson and Johnson
06/04/202400:21PR Newswire (US)CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of TherapyNYSE:JNJJohnson and Johnson
05/04/202415:55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.NYSE:JNJJohnson and Johnson
05/04/202408:38IH Market NewsApple Terminates 614 Employees, Disney Unveils June Crackdown on Password Sharing, and More UpdatesNYSE:JNJJohnson and Johnson
05/04/202407:31Business WireJohnson & Johnson to Acquire Shockwave MedicalNYSE:JNJJohnson and Johnson
04/04/202419:01Business WireJohnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment CorporationNYSE:JNJJohnson and Johnson
02/04/202417:30Business WireJohnson & Johnson to Participate in the BofA Securities Health Care ConferenceNYSE:JNJJohnson and Johnson
28/03/202410:48IH Market NewsWalgreens Slashes Annual Profit Forecast; MillerKnoll Nosedives 17% on Bleak 4Q Outlook, and Latest NewsNYSE:JNJJohnson and Johnson
27/03/202407:54IH Market NewsGameStop Shares Tumble 20% in Pre-Market Trading Amid Revenue Decline, Direct Digital Plummets 42%, and More NewsNYSE:JNJJohnson and Johnson
12/03/202410:15GlobeNewswire Inc.Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation ChallengeNYSE:JNJJohnson and Johnson
11/03/202417:30Business WireJohnson & Johnson to Host Investor Conference Call on First-Quarter ResultsNYSE:JNJJohnson and Johnson
07/03/202418:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:JNJJohnson and Johnson
07/03/202410:33Business WireJohnson & Johnson Completes Acquisition of AmbrxNYSE:JNJJohnson and Johnson
01/03/202417:59PR Newswire (US)RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion MutationsNYSE:JNJJohnson and Johnson
20/02/202418:26PR Newswire (US)TECVAYLI® (teclistamab-cqyv) biweekly dosing approved by the U.S. FDA for the treatment of patients with relapsed or refractory multiple myelomaNYSE:JNJJohnson and Johnson
16/02/202418:12Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:JNJJohnson and Johnson
16/02/202408:08IH Market NewsNike Workforce Reduction, The Trade Desk Soars 19% on $606 Million Revenue, and Latest NewsNYSE:JNJJohnson and Johnson
 Apresentando as notícias mais relevantes sobre:NYSE:JNJ

Seu Histórico Recente

NYSE
PBR
Petroleo Brasileiro ADR
NYSE
PBR.A
Petroleo Brasileiro ADR
BOV
BBDC4
BRADESCO PN
BOV
VALE3
VALE ON
COIN
LTCUSD
Litecoin
EU
PX1
CAC 40
COIN
BCHBTC
Bitcoin Cash
NYSE
GGB
Gerdau
BOV
GGBR4
GERDAU PN
BOV
BBAS3
BANCO DO BRASIL ON
COIN
XMRUSD
Monero
BOV
GFSA3
GAFISA ON
NYSE
RIO
Rio Tinto
BOV
B3SA3
B3 SA - Brasil Bolsa Bal... ON
BOV
ELET6
ELETROBRAS PNB
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados